Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) Institutional Ownership

13F Institutional Holders and Ownership History for Q4 2025

Type / Class
Equity / Ordinary Shares, par value $0.001 per share
Symbol
CBIO on Nasdaq
Shares outstanding
13,839,146
Price per share
$11.86
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
374,496
Total reported value
$4,441,098
% of total 13F portfolios
0%
Share change
+13,246
Value change
+$157,098
Number of holders
2
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
1Globe Capital LLC 10% +64% $20,839,816 +$7,729,886 1,425,432 +59% 1Globe Capital LLC 07 Oct 2025
FMR LLC 10% 1,414,190 FMR LLC 30 Jun 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% 1,391,196 Venrock Healthcare Capital Partners III, L.P. 13 Jun 2025
Adage Capital Management, L.P. 0.37% 50,912 Adage Capital Management, L.P. 20 Jun 2025

As of 31 Dec 2025, 2 institutional investors reported holding 374,496 shares of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO). This represents 2.7% of the company’s total 13,839,146 outstanding shares.

Institutional Holders of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 374,496 $4,441,098 +$157,098 $11.86 2